Case McNamara, PhD, is a senior director in the Infectious Disease Unit at Calibr, a division of The Scripps Research Institute. He completed his PhD studies in chemistry and biochemistry at the University of California, San Diego. He has more than 17 years of drug discovery experience against numerous neglected tropical diseases. He has been associated with six drug discovery programs that have entered clinical trials for malaria, cryptosporidiosis, COVID, and HIV. Currently, he oversees drug discovery efforts in leishmaniasis, Chagas disease, tuberculosis, malaria, schistosomiasis, cryptosporidiosis, and multiple viral families.
Case McNamara, PhD, is a senior director in the Infectious Disease Unit at Calibr, a division of The Scripps Research Institute. He completed his PhD studies in chemistry and biochemistry at the University of California, San Diego. He has more than 17 years of drug discovery experience against numerous neglected tropical diseases. He has been associated with six drug discovery programs that have entered clinical trials for malaria, cryptosporidiosis, COVID, and HIV. Currently, he oversees drug discovery efforts in leishmaniasis, Chagas disease, tuberculosis, malaria, schistosomiasis, cryptosporidiosis, and multiple viral families.